Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous-Cell Non-Small-Cell Lung Cancer 1

Interventions

Cyclophosphamide 98 pembrolizumab 85 Gemcitabine 81 Carboplatin 62 fludarabine 61 Nivolumab 57 Cisplatin 54 Paclitaxel 51 Radiotherapy 50 Docetaxel 49 Rituximab 46 Dexamethasone 42 Lenalidomide 41 Ipilimumab 38 Azacitidine 35 Etoposide 34 Cytarabine 33 Temozolomide 32 Bevacizumab 32 Radiation 29 venetoclax 28 Bortezomib 27 Magnetic Resonance Spectroscopy 26 Irinotecan 26 Pemetrexed 25 atezolizumab 24 Oxaliplatin 24 Capecitabine 24 fludarabine phosphate 22 Filgrastim 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Terminated × bemarituzumab × Clear all

NCT05267470 2025-03-25

FORTITUDE-201

Amgen

Phase 1 Terminated

74 enrolled 22 charts

Squamous-Cell Non-Small-Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡